Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Plos One|March 24, 2015
Incidence of HIV and the prevalence of HIV, hepatitis B and syphilis among youths in Maputo, Mozambique: a cohort studyEdna Omar Viegas, Nelson Tembe, Eulália Macovela, et al.
AIDS Research and Human Retroviruses|October 4, 2017
Intradermal HIV-1 DNA Immunization Using Needle-Free Zetajet Injection Followed by HIV-Modified Vaccinia Virus Ankara Vaccination Is Safe and Immunogenic in Mozambican Young Adults: A Phase I Randomized Controlled TrialEdna Omar Viegas, Nelson Tembe, Charlotta Nilsson, et al.
Frontiers in Immunology|May 16, 2020
Induction of Identical IgG HIV-1 Envelope Epitope Recognition Patterns After Initial HIVIS-DNA/MVA-CMDR Immunization and a Late MVA-CMDR BoostAgricola Joachim, Mohamed I M Ahmed, Georgios Pollakis, et al.
AIDS Research and Human Retroviruses|December 29, 2016
Three-Year Durability of Immune Responses Induced by HIV-DNA and HIV-Modified Vaccinia Virus Ankara and Effect of a Late HIV-Modified Vaccinia Virus Ankara Boost in Tanzanian VolunteersAgricola Joachim, Patricia J Munseri, Charlotta Nilsson, et al.
AIDS Research and Human Retroviruses|October 5, 2013
Broad and potent cellular and humoral immune responses after a second late HIV-modified vaccinia virus ankara vaccination in HIV-DNA-primed and HIV-modified vaccinia virus Ankara-boosted Swedish vaccineesCharlotta Nilsson, Karina Godoy-Ramirez, Bo Hejdeman, et al.
The Journal of Infectious Diseases|September 24, 2008
Broad immunogenicity of a multigene, multiclade HIV-1 DNA vaccine boosted with heterologous HIV-1 recombinant modified vaccinia virus AnkaraEric Sandström, Charlotta Nilsson, Bo Hejdeman, et al.
Scientific Reports|April 8, 2021
Evaluation of 11 SARS-CoV-2 antibody tests by using samples from patients with defined IgG antibody titersNina Lagerqvist, Kimia T Maleki, Jenny Verner-Carlsson, et al.
Vaccine|August 26, 2011
Broad and potent immune responses to a low dose intradermal HIV-1 DNA boosted with HIV-1 recombinant MVA among healthy adults in TanzaniaMuhammad Bakari, Said Aboud, Charlotta Nilsson, et al.
Microorganisms|November 7, 2020
Frequent Anti-V1V2 Responses Induced by HIV-DNA Followed by HIV-MVA with or without CN54rgp140/GLA-AF in Healthy African VolunteersFrank Msafiri, Agricola Joachim, Kathrin Held, et al.
Plos One|May 19, 2016
Boosting with Subtype C CN54rgp140 Protein Adjuvanted with Glucopyranosyl Lipid Adjuvant after Priming with HIV-DNA and HIV-MVA Is Safe and Enhances Immune Responses: A Phase I TrialAgricola Joachim, Asli Bauer, Sarah Joseph, et al.
Pageof 7